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In nature, hibernating animals encounter fasting, cold temperature and short day seasonally. Torpor is a state of decreased
physiological activity in an animal, usually characterized by a reduced body temperature and rate of metabolism to adapt such
a severe environment. Ablation of the central clock synchronizer, the suprachiasmatic nucleus in brain, abolishes torpor, a
hibernation-like state, implicating the circadian clock involved in this seasonal change. Biologists knows well the energy source
of daily heterotherms/hibernators changed from glucose to lipids in winter. Here we review several lines of evidence of a master
transcriptional regulator in lipid catabolism, PPARα, in the control of torpor through FGF21-NPY pathway. This indicate the
importance of circadian—and photoperiod—regulation of PPARα to tell seasons in our body.
Copyright © 2009 Norio Ishida. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Peroxisome proliferator-activated receptor a (PPARα)i sa
nuclearreceptorthatregulatesthetranscriptionofnumerous
genes involved in lipid metabolism and energy homeostasis
(1,2). Binding of ligands such as fatty acids or ﬁbrate
to PPARα leads to obligate heterodimerization with 9-cis
retinoic acid receptor (RXR) and subsequent recruitment of
coactivators, resulting in the initiation of DNA transcription
of target genes [1]. Recent studies have revealed that PPARα-
induced ﬁbroblast growth factor 21 (FGF21) plays an impor-
tant role in adaptation to fasting, such as adipose lipolysis,
hepatic ketogenesis and torpor [2–6]. Torpor is often used
to help animals survive during periods of winter, and it
considered as the state in between sleep and hibernation.
In torpor, it is well kown that the energy source of daily
heterothermschangedfromglucosetolipidsinwinter.Taken
together, FGF21 might be a key regulator for torpor in
mice [5]. The metabolic regulator FGF21 has antidiabetic
properties in animal models of diabetes and obesity. Recent
papers showed that the hepatic gene expression of FGF21 is
regulated by PPARα [2–4]. Fasting or treatment of mice with
the PPARα agonist Wy-14,643 induced FGF21 mRNA by
ca.10-fold [4]. In contrast, FGF21 mRNA was low in PPARα
deﬁcient mice, and fasting or treatment with Wy-14,643
did not induce FGF21. Obese ob/ob mice, known to have
increased PPARα levels, displayed 12-fold increased hepatic
FGF21 mRNA levels. The importance of PPARα for FGF21
expressioneveninhumanliverwasalsoshownbyWy-14,643
induction of FGF21 mRNA in human primary hepatocytes.
Furthermore, PPARα response elements were identiﬁed in
both the human and mouse FGF21 promoters [4]. At least
in mice, within 1.5kb upstream region, two putative PPARα
response elements were detected by using promoter-deletion
assay and chromatin immunoprecipitaton [2].
ThebehaviorandphysiologyfromDrosophilatomanare
subject to circadian, 24-hour rhythmicity. Recent molecular
studies show that circadian clock are controlled by negative
feedback loops in clock gene expression. The circadian clock,
an endogenous cell-autonomous machinery of rhythmically
acting transcriptional and translational feedback loop. The
circadian clock positive transcription factor, CLOCK and
BMAL1 transactivates other negative limbs of clock genes
such as period (per), cryptochrome (cry) via cis-element E-
box in their promoters (Figure 1)[ 7–9]. These negative2 PPAR Research
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Figure 1: Negative transcriptional feedback loop for 24hrs rhythm
generation in manmals. The circadian clock positive transcription
factor, CLOCK and BMAL1 transactivates other negative limbs of
clock genes such as period (per), cryptochrome (cry) via cis-element
E-box in their promoters. These negative components PER and
CRY, in turn, suppress the activity of CLOCK/Bmal during about
24hrs.
components PER and CRY, in turn, suppress the activ-
ity of CLOCK/Bmal. At least eleven clock genes (clock,
period1/2, Bmal1, cry1/2, E4BP4, b-TrCP1/2 casein kinase1
and glycogen synthase kinase 3b) generate circadian rhythms
in mammals, where most of these genes were identiﬁed
as homologues from Drosophila clock genes except for
Clock [10]. Molecules generally of transcription factors that
oscillate over a 24-hour period control their own expression
in a circadian fashion seem critical to the generation
of circadian rhythm of most organisms [7, 9]. However,
except for transcriptional proteins, some kinases that are
involved in these transcrptional protein degradation (casein
kinase 1 and b-TrCPs ) and nuclear translocation (glycogen
synthase kinase 3b) are also important for ﬁne-tuning the
concentration of clock molecules at speciﬁc subcellular sites
[9, 10].
The suprachiasmatic nucleus (SCN) of the anterior
hypothalamus in mammals is the central oscillator that
shynchronized by stimuli such as light in mammals [7,
9]. In contrast, regular mealtimes induce food-anticipatory
behavioralrhythmswithcircadianpropertiessimilartothose
of light-entrainable rhythms [11–13] and set the phase of
circadian oscillators in most peripheral organs. Interestingly,
these food-entrainable oscillator (FEO) did not require SCN
suggesting that FEO is the other brain region except for
SCN or peripheral tissues. Other peripheral tissues are
also equipped with endogenous oscillators using clock gene
products. In general, the expression of mRNA and proteins
of mammalian clock genes in the SCN as well as other
peripheral tissues oscillates in a robust circadian manner
Thus, the oscillation of such clock genes is a useful marker
for determining the phase and period of peripheral clocks
and the central clock(SCN) [14, 15]. Only recently the
importance of circadian system has become apparent for
the regulation of lipid metabolism, especially for rhythmic
PPARα expression because of a convergence of data from
microarray analysis using clock mutants animals [10, 16].
Furthermore, a role of clock gene products is considered for
stress sensor for cold, short day and no-food in winter. In
this review, I will summarize recent progress whether PPARα
plays a signiﬁcant role in regulating speciﬁc metabolic
pathways strongly associated with torpor/circadian rhythm.
2. CircadianExpressionof PPARα through
Clock GeneProducts
PPARα (peroxisome-proliferator-activated receptor α)i sa
member of the nuclear receptor superfamily and it plays a
central role in fatty acids oxidation [6, 17]. Interestingly,
fatty acids can function as endogenous ligand for PPARα.
Hepatic PPARα is expressed in a circadian manner at the
mRNA and protein levels in rats [18] and in mice [19]. The
circadian expression of PPARα was thought to be regulated
by unknown transcriptional molecular mechanism.
But the recent study examined the expression proﬁle
of PPARα in Clock mutant mice that are deﬁcient for the
circadian clock for locomotor activity. This showed that
the circadian expression of PPARα was dampened in Clock
mutant mice, because the circadian expression of PPARα
is regulated directly by clock gene product CLOCK protein
via the E-box-rich region in the second intron of PPARα in
vivo and in vitro [20]. The periodicity of homozygous Clock
mutant mouse behaviour [21, 22]a n db o d yt e m p e r a t u r e
[23] is abnormally long. As the Clock allele is truncated
and causes a deletion of 51 amino acids, the mutation
presumably would not have a signiﬁcant eﬀect on protei-
protein binding domains, leaving CLOCK dimerization and
DNA binding intact. The mutant CLOCK protein can still
form heterodimers with BMAL1 that bind to DNA, but
these are deﬁcient in transactivation [7, 16]. The results
suggest that CLOCK/Bmal play an important role in lipid
oxidation during the speciﬁc time of a day by regulating
the circadian transactivation of PPARα in mice. To further
support this notion, Turek et al showed that Clock mutant
mice become obese and developed dyslipidemia [24]. We
also showed that leptin deﬁcient obese mice ob/ob with
Clock homozygousmutantation gained body weight, total
cholesterol and triglyceride through adipocyte hypertrophy.
These obese phenotype might be explained partly because of
dampening for the circadian expression of PPAR [20, 25].
3. CircadianFGF21Inductionthrough
PPARα ActivationinLiver
Fasting remarkably increases hepatic FGF21 mRNA lev-
els due to PPARα activation via PPAR binding elements
in the FGF21 promoter [2, 4]. Within 22 members of
ﬁbroblast growth factor (FGF) family, FGF21 was classiﬁed
as metabolic hormones in the FGF19 subfamily, which
comprisesFGF19(mouseFGF15),FGF21andFGF23[6,26].
These FGFs are distinguished from other FGFs in that they
function in an endocrine fashion presumably due to having
low aﬃnity for heparin. Notably, FGF21 reported to enter
into the brain through the blood-brain barrier from liver
andkidney[27].Werecentlyshowedthatadministeringmice
with bezaﬁbrate, a PPARα ligand, induces time-dependentPPAR Research 3
torpor-like phenomena, decreased body temperature during
the latter half of the dark period as explained precisely in
the next chapter [28]. The PPARα-FGF21 pathway could
be involved in these torpor-like phenomena, because body
temperature decreases with time-dependent manner in fast-
ing FGF21 transgenic mice and in the fasting mice infected
with an adenovirus expressing FGF21 [2, 5]. However,
the mechanism underlying the time-dependent torpor-like
phenomena induced by the PPARα-FGF21 pathway has not
been elucidated. We also found that FGF21 expression is
regulated by a circadian mechanism in mice administered
with bezaﬁbrate [29]. We found that a nighttime injection
of bezaﬁbrate, a ligand of PPARα,e ﬀectively induced FGF21
expression, whereas a daytime injection did not aﬀectit. Fur-
thermore, bezaﬁbrate-induced circadian FGF21 expression
was abolished in PPARα-knock out mice. These observations
suggest that bezaﬁbrate-induced circadian FGF21 expression
is due to circadian variations in the responsiveness of the
PPARα system in the liver of laboratory mice.
4. TorporandNPYInductionbyPPARαAgonist
inLaboratoryMice
Torpor is a state of decreased physiological activity in an
animal, usually characterized by a reduced body temperature
and rate of metabolism [5, 30]. During the active part of
their day, these animals maintain normal body temperature
and activity levels, but their body temperature drops during
the latter half of dark phase. Torpor is often used to help
animals survive during periods of winter season, and it
considered as the state in between sleep and hibernation.
Animals like hummingbirds, bats and hamsters show torpor.
Siberian hamsters (Phodopus sungorus) undergo daily tor-
por during which body temperature decreases by as much
as 20 C degrees and provides a signiﬁcant savings in energy
expenditure [30] .N a t u r a lt o r p o ri nt h i ss p e c i e si sn o r m a l l y
triggered by winterlike (long day) photoperiods and low
ambient temperatures. Recent data demonstrate that intrac-
erebroventricular injection of neuropeptide Y (NPY) reliably
induces torpor like-hypothermia that resembles natural
torpor in hamsters. NPY-induced torpor like-hypothermia
is also produced by intracerebroventricular injections of
an NPY Y1 receptor agonist but not by injections of an
NPY Y5 receptor agonist. Both Y1 antagonist and Y5
antagonist injections signiﬁcantly reduced food ingestion 24
h after treatment. They conclude that activation of NPY Y1
receptors is both suﬃcient and necessary for NPY-induced
torpor-like hypothermia in hamsters.
First of all, we noticed that bezaﬁbrate, a ligand of
PPARα, advances the active phase of locomotor behavior in
wild type mice under 12h light-12h dark (LD) conditions
[31]. Next, bezaﬁbrate also advanced the phase in mice with
lesions of the suprachiasmatic nucleus (SCN; the central
clock in mammals) suggests that this phenomena depend
on FEO. The circadian expression of clock genes such as
period2,BMAL1,andRev-erbalphawasalsophase-advanced
in various tissues (cortex, liver, and fat) without aﬀecting the
SCN. Bezaﬁbrate also phase-advanced the activity phase that
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Figure 2: The eﬀect of bezaﬁbrate on body temperature (BT).
(a) Time course (above) of BT in mice fed a control diet (open
circles), a bezaﬁbrate-containing diet (ﬁlled circles) or the control
diet following recovery (gray circles). Revised from reference No.29.
is delayed in model mice with delayed sleep phase syndrome
(DSPS) due to a Clock gene mutation. The data suggests
that PPARα is a potential therapeutic target of drugs to
treat circadian rhythm sleep disorders [31]. Furthermore,
interestingly enough, Bezaﬁbrate can advance the activity
onset housing the mice under a long day (18 h of light and
6 h of darkness: LD 18 : 6) like summer, but not under a
short day (LD 8 : 16) like winter [31]. These observations
suggest that PPARα is deeply involved in entrainment of the
circadianclocktodiﬀerentseasonalchangeofLDconditions.
Recently we also found out that bezaﬁbrate-feeding
alter sleep state and body temperature (BT) in laboratory
mice [28]. Two-weeks feeding of bezaﬁbrate decreased BT,
especially during the latter half of the dark period which
is very similar timing for torpor (Figure 2). BT rhythm
and sleep/wake rhythm were phase advanced about 2-3 h
by bezaﬁbrate-feeding as observed in the phase advance4 PPAR Research
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Figure 3: Role of PPARα in the control of torpor through FGF21-
NPY pathway. Environmental changes like food (fasting) and light
enter the body from PPARα and clock gene products, Clock/Bmal,
respectively. Clock/Bmal regulated-rhythmic PPARα expression.
PPARα directly transactivate FGF21 and FGF21 may enter brain
and eﬀect the expression of Neuropeptide Y(NPY). NPY can induce
torper through Y1 receptor for NPY.
of locomoter behavior. Bezaﬁbrate-feeding also increased
the electroencephalogram (EEG) delta-power in nonrapid
eye movement (NREM) sleep compared with the control
diet mice. Furthermore, bezaﬁbrate-treated mice showed
no rebound of EEG delta-power in NREM sleep after 6 h
sleep deprivation, suggesting that sleep depth of bezaﬁbrate-
treated mice is very high as observed in hibernation animals.
DNA microarray, and real-time RT-PCR analysis showed
that bezaﬁbrate-feeding increased levels of Neuropeptide
Y(NPY) mRNA in the hypothalamus at both Zeitgeber time
(ZT) 10 and ZT22, and decreased proopiomelanocortin-
alphamRNAinthehypothalamusatZT10inmaleICRmice.
Furthermore, the intracerebroventricular injection of antag-
onist for NPY Y1 receptor blocked torpor-like hypothermia,
butnotforEEGdelta-powerinNREMsleepinthemice[28].
As mentioned above, NPY is a key molecule for inducing
torpor inthenaturaltorpor animal, siberian hamsters.These
ﬁndings demonstrate that PPARα participate in the control
of torpor through NPY production in the hypothalamus
even in laboratory mice and suggest that activation of
PPARα enhance deep sleep and improve resistance to sleep
loss through unknown mechanisms. But I do not exclude
the possibility that PPARα activated lipid metabolites and
ketogenesis mayhavearolefortorpor viaunknown pathway.
Thus, I would propose a new model for a role of PPARα
in the control of torpor through FGF21-NPY pathway
(Figure 3). This model may partly explain the importance
of circadian—and photoperiod—regulation of PPARα to
tell seasons in our body. This PPARα-FGF21-NPY pathway
might be a missing link between circadian clock and seasonal
clock.
Acknowledgments
The author thanks helpful discussion for Drs, N. Ibuka
(Shiga), H. Sei (Tokushima) and K. Oishi (Tsukuba), and
ﬁnancial support from AIST, METI.
References
[1] B. Desvergne and W. Wahli, “Proxisome proliferators-
activated receptors: nuclear control of metabolism,” Endocrine
Reviews, vol. 20, no. 5, pp. 649–688, 1999.
[ 2 ]T .I n a g a k i ,P .D u t c h a k ,G .Z h a o ,e ta l . ,“ E n d o c r i n er e g u l a t i o n
of the fasting response by PPARα-mediated induction of
ﬁbaroblast growth factor 21,” Cell Metabolism,v o l .5 ,n o .6 ,
pp. 415–425, 2007.
[3] M. K. Badman, P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier,
and E. Maratos-Flier, “Hepatic ﬁbroblast growth factor 21 is
regulated by PPARα and is a key mediator of hepatic lipid
metabolism in ketotic states,” Cell Metabolism, vol. 5, no. 6,
pp. 426–437, 2007.
[4] T. Lund˚ asen, M. C. Hunt, L.-M. Nilsson, et al., “PPARα is a
key regulator of hepatic FGF21,” Biochemical and Biophysical
Research Communications, vol. 360, no. 2, pp. 437–440, 2007.
[5] M. L. Reitman, “FGF21: a missing link in the biology of
fasting,” Cell Metabolism, vol. 5, no. 6, pp. 405–407, 2007.
[ 6 ]D .D .M o o r e ,“ P h y s i o l o g y :s i s t e ra c t , ”Science, vol. 316, no.
5830, pp. 1436–1438, 2007.
[7] J. Dunlap, “Molecular bases for circadian circadian clocks,”
Cell, vol. 96, no. 2, pp. 271–290, 1999.
[8] N. Ishida, M. Kaneko, and R. Allada, “Biological clocks,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 96, no. 16, pp. 8819–8820, 1999.
[9] U. Schibler and P. Sassone-Corsi, “A web of circadian pace-
makers,” Cell, vol. 111, no. 7, pp. 919–922, 2002.
[10] N. Ishida, “Circadian clock, cancer and lipid metabolism,”
Neuroscience Research, vol. 57, no. 4, pp. 483–490, 2007.
[11] U. Schibler, J. Ripperger, and S. A. Brown, “Peripheral
circadian oscillators in mammals: time and food,” Journal of
Biological Rhythms, vol. 18, no. 3, pp. 250–260, 2003.
[12] B. Staels, “When the Clock stops ticking, metabolic syndrome
explodes,” Nature Medicine, vol. 12, no. 1, pp. 54–55, 2006.
[13] R. E. Mistlberger, S. Yamazaki, J. S. Pendergast, G. J. Landry, T.
Takumi, and W. Nakamura, “Comment on “diﬀerential rescue
oflight-andfood-entrainablecircadianrhythms”,”Science,vol.
322, no. 5902, p. 675, 2008.
[14] S.-H. Yoo, S. Yamazaki, P. L. Lowrey, et al.,
“PERIOD2::LUCIFERASE real-time reporting of circadian
dynamics reveals persistent circadian oscillations in mouse
peripheral tissues,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 101, no. 15, pp.
5339–5346, 2004.
[15] K.Sakamoto,T.Nagase,H.Fukui,etal.,“Multitissuecircadian
expression of rat period homolog (rPer2)m R N Ai sg o v e r n e d
by the mammalian circadian clock, the suprachiasmatic
nucleus in the brain,” The Journal of Biological Chemistry, vol.
273, no. 42, pp. 27039–27042, 1998.
[16] P. L. Lowrey and J. S. Takahashi, “Mammalian circadian
biology: elucidating genome-wide levels of temporal organi-
zation,” Annual Review of Genomics and Human Genetics, vol.
5, pp. 407–441, 2004.
[17] T. C. Leone, C. J. Weinheimer, and D. P. Kelly, “A critical role
for the peroxisome proliferators-activated receptor α (PPARα)PPAR Research 5
in the cellular fasting response: the PPARα-null mouse as a
model of fatty acid oxidation disorders,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 96, no. 13, pp. 7473–7478, 1999.
[18] T. Lemberger, R. Saladin, M. V´ azquez, et al., “Expression
of the peroxisome proliferator-activated receptor α gene is
stimulatedbystressandfollowsadiurnalrhythm,”TheJournal
of Biological Chemistry, vol. 271, no. 3, pp. 1764–1769, 1996.
[19] D. D. Patel, B. L. Knight, D. Wiggins, S. M. Humphreys, and
G. F. Gibbons, “Disturbances in the normal regulation of
SREBP-sensitive genes in PPARα-deﬁcient mice,” Journal of
Lipid Research, vol. 42, no. 3, pp. 328–337, 2001.
[20] K. Oishi, H. Shirai, and N. Ishida, “CLOCK is involved in the
circadian transactivation of peroxisome-proliferator-activated
receptor α(PPARα)inmice,”BiochemicalJournal,vol.386,no.
3, pp. 575–581, 2005.
[21] M. H. Vitaterna, D. P. King, A. M. Chang, et al., “Mutagenesis
and mapping of a mouse gene, Clock, essential for circadian
behavior,” Science, vol. 264, no. 5159, pp. 719–725, 1994.
[22] K. Oishi, K. Miyazaki, and N. Ishida, “Functional CLOCK
is not involved in the entrainment of peripheral clocks to
the restricted feeding: entrainable expression of mPer2 and
BMAL1 mRNAs in the heart of Clock mutant mice on
Jcl:ICR background,” Biochemical and Biophysical Research
Communications, vol. 298, no. 2, pp. 198–202, 2002.
[23] F. W. Turek, C. Joshu, A. Kohsaka, et al., “Obesity and
metabolic syndrome in circadian Clock mutant mice,” Science,
vol. 308, no. 5724, pp. 1043–1045, 2005.
[24] K. Oishi, N. Ohkura, M. Wakabayashi, et al., “CLOCK is
involved in obesity-induced disordered ﬁblynosis in ob/ob
mice by regulating PAI-1 gene expression,” Journal of Throm-
bosis and Haemostasis, vol. 4, no. 8, pp. 1774–1780, 2006.
[25] N. Itoh and D. M. Ornitz, “Evolution of the Fgf and Fgfr gene
families,”Trends in Genetics,vol.20,no.11,pp.563–569,2004.
[26] H. Hsuchou, W. Pan, and A. J. Kastin, “The fasting polypep-
tide FGF21 can enter brain from blood,” Peptides, vol. 28, no.
12, pp. 2382–2386, 2007.
[27] S. Chikahisa, K. Tominaga, T. Kawai, et al., “Bezaﬁbrate, a
peroxisome proliferator-activated receptors agonist, decreases
body temperature and enhances electroencephalogram delta-
oscillation during sleep in mice,” Endocrinology, vol. 149, no.
10, pp. 5262–5271, 2008.
[28] K. Oishi, D. Uchida, and N. Ishida, “Circadian expression of
FGF21 is induced by PPARα activation in the mouse liver,”
FEBS Letters, vol. 582, no. 25-26, pp. 3639–3642, 2008.
[29] J. Dark and K. M. Pelz, “NPY Y1 receptor antagonist prevents
NPY-induced torporlike hypothermia in cold-acclimated
Siberian hamsters,” American Journal of Physiology, vol. 294,
no. 1, pp. R236–R245, 2008.
[30] H. Shirai, K. Oishi, T. Kudo, S. Shibata, and N. Ishida, “PPARα
is a potential therapeutic target of drugs to treat circadian
rhythm sleep disorders,” Biochemical and Biophysical Research
Communications, vol. 357, no. 3, pp. 679–682, 2007.
[31] K. Oishi, H. Shirai, and N. Ishida, “PPARα is involved in
photoentrainment of the circadian clock,” NeuroReport, vol.
19, no. 4, pp. 487–489, 2008.